Continuing to Deepen Presence in the Chinese Market, Serving the World with Local Innovation and Smart Manufacturing
SHENZHEN, ChinaApril 27, 2026 /PRNewswire/ — Today, the Philips Respironics Shenzhen production base has been revitalized and officially unveiled. Philips’ investment in upgrading this base aims to further strengthen its local innovation and smart manufacturing footprint, driving supply chain upgrades. This marks the latest practice of the company’s long-term commitment to “In China, For China, Benefit the World.”
Liu Ling, Member of the Global Executive Committee of Philips and President of Philips Greater China, stated: “China is not only one of our most important global markets but also a key force leading technological innovation and advanced manufacturing. Our investment in upgrading the Philips Respironics Shenzhen production and R&D base will open a new chapter in advanced smart manufacturing in China. We will continue to accelerate the development of new quality productive forces, helping the medical manufacturing industry upgrade toward high quality, precision manufacturing, and intelligent solutions, providing more reliable respiratory care solutions to patients worldwide.”
The upgraded Philips Respironics Shenzhen production and R&D base will focus on high-complexity, high-value-added processes, undertaking core functions such as new product introduction, precision manufacturing, and automated process development. Products will be sold to global markets including North America, Europe, and Asia-Pacific. Leveraging the integrated advantages of the Guangdong-Hong Kong-Macao Greater Bay Area, the base will deeply integrate into regional coordinated development, enabling rapid flow of raw materials, talent, and technology. It will become Philips’ premier production and supply center for global respiratory business in the Asia-Pacific region, as well as a key hub serving the world within Philips’ global supply chain.
As a global leader in health technology, Philips has been deeply rooted in China for over 40 years since establishing its first joint venture in the country in 1985. Currently, Philips operates five production bases and multiple R&D centers in China, forming a full-chain localization capability covering R&D, manufacturing, and services, enabling Chinese R&D and manufacturing to supply the world. Based in the Chinese market, Philips will continue to develop higher-quality respiratory care solutions, driving high-quality development of global healthcare services with Chinese innovation and smart manufacturing.